Oral Contraceptives and Cancer Risk - National Cancer Institute
ثبت نشده
چکیده
Key Points A number of studies suggest that current use of oral contraceptives (birth control pills) appears to slightly increase the risk of breast cancer, especially among younger women. However, the risk level goes back to normal 10 years or more after discontinuing oral contraceptive use. Women who use oral contraceptives have reduced risks of ovarian and endometrial cancer. This protective effect increases with the length of time oral contraceptives are used. Oral contraceptive use is associated with an increased risk of cervical cancer; however, this increased risk may be because sexually active women have a higher risk of becoming infected with human papillomavirus, which causes virtually all cervical cancers. Women who take oral contraceptives have an increased risk of benign liver tumors, but the relationship between oral contraceptive use and malignant liver tumors is less clear.
منابع مشابه
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
BACKGROUND Oral contraceptive use has been associated with an increase in the risk of breast cancer in young women. We examined whether this association is seen in women at high risk of breast cancer because they carry a mutation in one of two breast cancer susceptibility genes, BRCA1 and BRCA2. METHODS We performed a matched case-control study on 1311 pairs of women with known deleterious BR...
متن کاملOral contraceptive use and risk of gestational trophoblastic tumors.
BACKGROUND Gestational trophoblastic disease refers to a spectrum of rare benign and malignant gynecologic disorders whose pathogenesis is not well understood. Recent studies from China and the United States have raised the hypothesis that long-term use of oral contraceptives before conception may increase the risk of gestational trophoblastic tumors. A multicenter case-control study of gestati...
متن کاملReproductive history and risk of colorectal cancer in postmenopausal women.
BACKGROUND There are conflicting data regarding the role of sex hormones in colorectal cancer development. Whereas clinical trials data indicate that hormone therapy use reduces the risk of colorectal cancer, data from prospective cohort studies suggest that circulating estrogen levels are positively associated with colorectal cancer risk. A surrogate measure of lifetime estrogen exposure is re...
متن کاملModifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
BACKGROUND There is substantial variability in cancer risk in women who have inherited a BRCA1 or BRCA2 (BRCA1/2) mutation. Numerous factors have been hypothesized to modify these risks, but studies are of variable quality, and it remains unclear which of these may be of value in clinical risk assessment. METHODS PubMed and Web of Science databases were searched for articles published through...
متن کاملOral Contraceptives and Cancer Risk: Questions and Answers
Some cancers depend on naturally occurring sex hormones for their development and growth. Researchers are interested in learning whether the hormones in oral contraceptives affect cancer risk in women (see Question 1). Some studies have shown an increased risk of breast cancer in women taking oral contraceptives, while other studies have shown no change in risk (see Question 2). Oral cont...
متن کامل